BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beckman G, Birgander R, Själander A, Saha N, Holmberg PA, Kivelä A, Beckman L. Is p53 polymorphism maintained by natural selection. Hum Hered. 1994;44:266-270. [PMID: 7927355 DOI: 10.1159/000154228] [Cited by in Crossref: 216] [Cited by in F6Publishing: 210] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Skhoun H, Khattab M, Belkhayat A, Takki Chebihi Z, Bakri Y, Dakka N, El Baghdadi J. Association of TP53 gene polymorphisms with the risk of acute lymphoblastic leukemia in Moroccan children. Mol Biol Rep 2022. [PMID: 35705773 DOI: 10.1007/s11033-022-07643-3] [Reference Citation Analysis]
2 Lo Piccolo L, Jantrapirom S, Moonmuang S, Teeyakasem P, Pasena A, Suksakit P, Charoenkwan P, Pruksakorn D, Koonrungsesomboon N. In search of TP53 mutational hot spots for Li-Fraumeni syndrome in Asian populations. Trop Med Int Health 2021;26:1401-10. [PMID: 34478609 DOI: 10.1111/tmi.13673] [Reference Citation Analysis]
3 Lodhi N, Singh R, Rajput SP, Saquib Q. SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection. Int J Mol Sci 2021;22:8660. [PMID: 34445373 DOI: 10.3390/ijms22168660] [Reference Citation Analysis]
4 Sindi IA, Babalghith AO, Tayeb MT, Mufti AH, Naffadi H, Ekram SN, Elhawary EN, Alenezi M, Elhawary NA. Risk of Colorectal Carcinoma May Predispose to the Genetic Variants of the GST, CYP450, and TP53 Genes Among Nonsmokers in the Saudi Community. Int J Gen Med 2021;14:1311-23. [PMID: 33883929 DOI: 10.2147/IJGM.S294802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 De Souza C, Madden J, Koestler DC, Minn D, Montoya DJ, Minn K, Raetz AG, Zhu Z, Xiao WW, Tahmassebi N, Reddy H, Nelson N, Karnezis AN, Chien J. Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer. J Natl Cancer Inst 2021:djab019. [PMID: 33555293 DOI: 10.1093/jnci/djab019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Doffe F, Carbonnier V, Tissier M, Leroy B, Martins I, Mattsson JSM, Micke P, Pavlova S, Pospisilova S, Smardova J, Joerger AC, Wiman KG, Kroemer G, Soussi T. Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene. Cell Death Differ 2021;28:1477-92. [PMID: 33257846 DOI: 10.1038/s41418-020-00672-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Humpton T, Vousden KH. Taking up the reins of power: metabolic functions of p53. J Mol Cell Biol 2019;11:610-4. [PMID: 31282931 DOI: 10.1093/jmcb/mjz065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Liu P, Zhuo ZJ, Zhu J, Yang Z, Xin Y, Li S, Li L, Li Y, Wang H, He J. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study. J Gene Med 2020;22:e3182. [PMID: 32166848 DOI: 10.1002/jgm.3182] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Dmytrzak A, Boroń A, Łoniewska B, Lewandowska K, Gorący I, Kaczmarczyk M, Ciechanowicz A. Two Functional TP53 Genetic Variants and Predisposition to Keloid Scarring in Caucasians. Dermatol Res Pract 2019;2019:6179063. [PMID: 31827503 DOI: 10.1155/2019/6179063] [Reference Citation Analysis]
10 Ozola A, Ruklisa D, Pjanova D. The complementary effect of rs1042522 in TP53 and rs1805007 in MC1R is associated with an elevated risk of cutaneous melanoma in Latvian population. Oncol Lett 2019;18:5225-34. [PMID: 31612033 DOI: 10.3892/ol.2019.10906] [Reference Citation Analysis]
11 Kuguyo O, Tsikai N, Thomford NE, Magwali T, Madziyire MG, Nhachi CFB, Matimba A, Dandara C. Genetic Susceptibility for Cervical Cancer in African Populations: What Are the Host Genetic Drivers? OMICS 2018;22:468-83. [PMID: 30004844 DOI: 10.1089/omi.2018.0075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Labuschagne CF, Zani F, Vousden KH. Control of metabolism by p53 - Cancer and beyond. Biochim Biophys Acta Rev Cancer 2018;1870:32-42. [PMID: 29883595 DOI: 10.1016/j.bbcan.2018.06.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 16.8] [Reference Citation Analysis]
13 Huszno J, Grzybowska E. TP53 mutations and SNPs as prognostic and predictive factors in patients with breast cancer. Oncol Lett 2018;16:34-40. [PMID: 29928384 DOI: 10.3892/ol.2018.8627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
14 Mascelli S, Nozza P, Jones DT, Colin C, Pistorio A, Milanaccio C, Ravegnani M, Consales A, Witt O, Morana G, Cama A, Capra V, Biassoni R, Pfister SM, Figarella-Branger D, Garrè ML, Raso A. TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma. Oncotarget 2016;7:47918-26. [PMID: 27374106 DOI: 10.18632/oncotarget.10295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Basu S, Gnanapradeepan K, Barnoud T, Kung CP, Tavecchio M, Scott J, Watters A, Chen Q, Kossenkov AV, Murphy ME. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α. Genes Dev 2018;32:230-43. [PMID: 29463573 DOI: 10.1101/gad.309062.117] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 10.8] [Reference Citation Analysis]
16 Tanara G, Falugi C, Cesario A, Margaritora S, Russo P, Cosimi A. TP53 Codon 72 Polymorphism does not Affect Risk of Cervical Cancer in Patients from the Gambia. Int J Biol Markers 2003;18:280-3. [DOI: 10.1177/172460080301800405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
17 Asadi M, Shanehbandi D, Zarintan A, Pedram N, Baradaran B, Zafari V, Shirmohamadi M, Hashemzadeh S. TP53 Gene Pro72Arg (rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population. Asian Pac J Cancer Prev 2017;18:3423-7. [PMID: 29286614 DOI: 10.22034/APJCP.2017.18.12.3423] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
18 Chen X, Mims J, Huang X, Singh N, Motea E, Planchon SM, Beg M, Tsang AW, Porosnicu M, Kemp ML, Boothman DA, Furdui CM. Modulators of Redox Metabolism in Head and Neck Cancer. Antioxid Redox Signal 2018;29:1660-90. [PMID: 29113454 DOI: 10.1089/ars.2017.7423] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
19 Habyarimana T, Attaleb M, Mugenzi P, Mazarati JB, Bakri Y, El Mzibri M. Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population. Pathobiology 2018;85:186-91. [PMID: 29131100 DOI: 10.1159/000481664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Kung CP, Liu Q, Murphy ME. The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation. Cancer Biol Ther 2017;18:484-91. [PMID: 28475405 DOI: 10.1080/15384047.2017.1323595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
21 Chuery ACS, Silva IDCGD, Ribalta JCL, Speck NMDG. Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression. The Brazilian Journal of Infectious Diseases 2017;21:248-54. [DOI: 10.1016/j.bjid.2017.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
22 Kodal JB, Vedel-Krogh S, Kobylecki CJ, Nordestgaard BG, Bojesen SE. TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals. Sci Rep 2017;7:336. [PMID: 28336930 DOI: 10.1038/s41598-017-00427-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
23 Yang J, Zhu J, Wu S, Li J, Wang M, Wang T, Lu Y. Association study between the TP53 Rs1042522G/C polymorphism and susceptibility to systemic lupus erythematosus in a Chinese Han population. Rheumatol Int 2017;37:523-9. [DOI: 10.1007/s00296-017-3662-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
24 Chan Y, Zhu B, Jiang H, Zhang J, Luo Y, Tang W. Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome. PLoS One 2016;11:e0167147. [PMID: 27898708 DOI: 10.1371/journal.pone.0167147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
25 Hossain A, Murshid GMM, Zilani MNH, Islam F, Sultana R, Sultana T, Hossain MG, Rahman MM. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population. Breast Cancer 2017;24:571-8. [PMID: 27837441 DOI: 10.1007/s12282-016-0740-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
26 Mendes de Oliveira C, Levi JE. The Biological Impact of Genomic Diversity in Cervical Cancer Development. Acta Cytol 2016;60:513-7. [PMID: 27771695 DOI: 10.1159/000449401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
27 Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH, Maruo T. Polymorphism at Codon 72 of the p53 Gene Is Not associated With Endometriosis in a Japanese Population. Journal of the Society for Gynecologic Investigation 2016;11:232-6. [DOI: 10.1016/j.jsgi.2003.11.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
28 Ostrow SL, Hershberg R. The Somatic Nature of Cancer Allows It to Affect Highly Constrained Genes. Genome Biol Evol 2016;8:1614-20. [PMID: 27190005 DOI: 10.1093/gbe/evw110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Basu S, Murphy ME. Genetic Modifiers of the p53 Pathway. Cold Spring Harb Perspect Med 2016;6:a026302. [PMID: 27037420 DOI: 10.1101/cshperspect.a026302] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
30 Kung CP, Leu JI, Basu S, Khaku S, Anokye-Danso F, Liu Q, George DL, Ahima RS, Murphy ME. The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. Cell Rep 2016;14:2413-25. [PMID: 26947067 DOI: 10.1016/j.celrep.2016.02.037] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 11.5] [Reference Citation Analysis]
31 Jacovas VC, Rovaris DL, Peréz O, de Azevedo S, Macedo GS, Sandoval JR, Salazar-Granara A, Villena M, Dugoujon JM, Bisso-Machado R, Petzl-Erler ML, Salzano FM, Ashton-Prolla P, Ramallo V, Bortolini MC. Genetic Variations in the TP53 Pathway in Native Americans Strongly Suggest Adaptation to the High Altitudes of the Andes. PLoS One 2015;10:e0137823. [PMID: 26382048 DOI: 10.1371/journal.pone.0137823] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
32 Xi Y, Liu C, Xin X. Association between a single nucleotide polymorphism in the TP53 region and risk of ovarian cancer. Cell Biochem Biophys 2014;70:1907-12. [PMID: 25060098 DOI: 10.1007/s12013-014-0150-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
33 de Oliveira CM, Bravo IG, Santiago e Souza NC, Genta ML, Fregnani JH, Tacla M, Carvalho JP, Longatto-Filho A, Levi JE. High-level of viral genomic diversity in cervical cancers: A Brazilian study on human papillomavirus type 16. Infect Genet Evol 2015;34:44-51. [PMID: 26160543 DOI: 10.1016/j.meegid.2015.07.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
34 Ndiaye R, Dem A, Mbaye PM, Guèye PM, Diop G, Diop PA, Faye O. [Study of codon 72 of p53 gene as a risk-factor in cervical cancer in Senegal]. Bull Cancer 2014;101:789-94. [PMID: 25025520 DOI: 10.1684/bdc.2014.1911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
35 Chen H, Deng X, Yang Y, Shen Y, Chao L, Wen Y, Sun Y. Expression of GRIM-19 in missed abortion and possible pathogenesis. Fertility and Sterility 2015;103:138-146.e3. [DOI: 10.1016/j.fertnstert.2014.10.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
36 Panni S, Salvioli S, Santonico E, Langone F, Storino F, Altilia S, Franceschi C, Cesareni G, Castagnoli L. The adapter protein CD2AP binds to p53 protein in the cytoplasm and can discriminate its polymorphic variants P72R. J Biochem. 2015;157:101-111. [PMID: 25261582 DOI: 10.1093/jb/mvu059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
37 Kung CP, Khaku S, Jennis M, Zhou Y, Murphy ME. Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes. Mol Cancer Res 2015;13:250-62. [PMID: 25256710 DOI: 10.1158/1541-7786.MCR-14-0385] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
38 Mostaid MS, Ahmed MU, Islam MS, Bin Sayeed MS, Hasnat A. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population. Tumor Biol 2014;35:10309-17. [DOI: 10.1007/s13277-014-2285-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
39 Chicheva Z, Chelenkova P, Petkova R, Chakarov S. Children of the Sun, Children of the Moon—A Mini-Panel for Assessment of Inter-Individual Variation Between the Capacity of Healthy Individuals to Repair Everyday Genotoxic Insults. Biotechnology & Biotechnological Equipment 2014;26:3142-7. [DOI: 10.5504/bbeq.2012.0052] [Cited by in Crossref: 7] [Article Influence: 0.9] [Reference Citation Analysis]
40 Bodian DL, McCutcheon JN, Kothiyal P, Huddleston KC, Iyer RK, Vockley JG, Niederhuber JE. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing. PLoS One. 2014;9:e94554. [PMID: 24728327 DOI: 10.1371/journal.pone.0094554] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
41 Gai PP, Meese S, Bedu-Addo G, Gahutu JB, Mockenhaupt FP. No association of the p53 codon 72 polymorphism with malaria in Ghanaian primiparae and Rwandan children. Am J Trop Med Hyg 2014;90:1133-4. [PMID: 24710610 DOI: 10.4269/ajtmh.14-0050] [Reference Citation Analysis]
42 Eskander EF, Abd-Rabou AA, Yahya SM, El Sherbini A, Mohamed MS, Shaker OG. "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences". Indian J Clin Biochem 2014;29:3-7. [PMID: 24478542 DOI: 10.1007/s12291-013-0317-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Zeron-Medina J, Wang X, Repapi E, Campbell MR, Su D, Castro-Giner F, Davies B, Peterse EF, Sacilotto N, Walker GJ, Terzian T, Tomlinson IP, Box NF, Meinshausen N, De Val S, Bell DA, Bond GL. A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection. Cell 2013;155:410-22. [PMID: 24120139 DOI: 10.1016/j.cell.2013.09.017] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 9.9] [Reference Citation Analysis]
44 Raj SM, Pagani L, Gallego Romero I, Kivisild T, Amos W. A general linear model-based approach for inferring selection to climate. BMC Genet 2013;14:87. [PMID: 24053227 DOI: 10.1186/1471-2156-14-87] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
45 Azzam G, Wang X, Bell D, Murphy ME. CSF1 is a novel p53 target gene whose protein product functions in a feed-forward manner to suppress apoptosis and enhance p53-mediated growth arrest. PLoS One 2013;8:e74297. [PMID: 24019961 DOI: 10.1371/journal.pone.0074297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
46 Chiurillo MA, Griman P, Santiago L, Torres K, Moran Y, Borjas L. Distribution of GSTM1, GSTT1, GSTP1 and TP53 disease-associated gene variants in native and urban Venezuelan populations. Gene 2013;531:106-11. [PMID: 23994684 DOI: 10.1016/j.gene.2013.08.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
47 Chen F, Ou-yang F, Yang S, Tsai E, Hou M. p53 codon 72 polymorphism in Taiwanese breast cancer patients. The Kaohsiung Journal of Medical Sciences 2013;29:259-64. [DOI: 10.1016/j.kjms.2012.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
48 Lajin B, Alhaj Sakur A, Alachkar A. Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women. Breast Cancer Res Treat 2013;138:611-9. [PMID: 23468244 DOI: 10.1007/s10549-013-2467-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
49 Huang SX, Wu FX, Luo M, Ma L, Gao KF, Li J, Wu WJ, Huang S, Yang Q, Liu K, Zhao YN, Li LQ. The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analysis of 28 case-control studies. PLoS One 2013;8:e56722. [PMID: 23437223 DOI: 10.1371/journal.pone.0056722] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
50 Sagne C, Marcel V, Amadou A, Hainaut P, Olivier M, Hall J. A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects. Cell Death Dis 2013;4:e492. [PMID: 23412385 DOI: 10.1038/cddis.2013.24] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
51 Leu JI, Murphy ME, George DL. The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver. J Liver 2013;2:117. [PMID: 23991369 DOI: 10.4172/2167-0889.1000117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
52 Salehi Z, Hadavi M. Analysis of the codon 72 polymorphism of TP53 and human papillomavirus infection in Iranian patients with prostate cancer. J Med Virol 2012;84:1423-7. [PMID: 22825821 DOI: 10.1002/jmv.23268] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
53 Ohnstad HO, Castro R, Sun J, Heintz KM, Vassilev LT, Bjerkehagen B, Kresse SH, Meza-Zepeda LA, Myklebost O. Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma. Cancer 2013;119:1013-22. [PMID: 23165797 DOI: 10.1002/cncr.27837] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
54 Burroni E, Bisanzi S, Sani C, Puliti D, Carozzi F. Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix. J Med Virol 2013;85:83-90. [PMID: 23124863 DOI: 10.1002/jmv.23417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
55 Hu J, Yao H, Gan F, Tokarski A, Wang Y. Interaction of OKL38 and p53 in regulating mitochondrial structure and function. PLoS One 2012;7:e43362. [PMID: 22912861 DOI: 10.1371/journal.pone.0043362] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
56 Jia S, Tang W, Luo Y. p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis. Hepatol Int 2013;7:669-75. [PMID: 26201800 DOI: 10.1007/s12072-012-9389-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
57 Almeida A. Genetic determinants of neuronal vulnerability to apoptosis. Cell Mol Life Sci 2013;70:71-88. [PMID: 22695677 DOI: 10.1007/s00018-012-1029-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
58 Giaimo S, d'Adda di Fagagna F. Is cellular senescence an example of antagonistic pleiotropy? Aging Cell 2012;11:378-83. [PMID: 22329645 DOI: 10.1111/j.1474-9726.2012.00807.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
59 Mustafina OE, Nasibullin TR, Erdman VV, Tuktarova IA. Analysis of the associations of polymorphic loci in TP53 and NFKB1 genes with human age and longevity. Adv Gerontol 2012;2:120-6. [DOI: 10.1134/s2079057012020129] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
60 Rybárová S, Vecanová J, Hodorová I, Mihalik J, Čižmáriková M, Mojžiš J, Solár P, Benický M, Adamkov M, Mirossay L. Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer. Med Sci Monit 2011;17:BR354-63. [PMID: 22129893 DOI: 10.12659/msm.882121] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
61 Pandith AA, Khan NP, Rashid N, Azad N, Zaroo I, Hafiz A, Siddiqi MA. Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir. Tumour Biol 2012;33:927-33. [PMID: 22249977 DOI: 10.1007/s13277-012-0318-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
62 Mashayekhi F, Hadiyan SP. A single-nucleotide polymorphism in TP53 may be a genetic risk factor for Iranian patients with idiopathic male infertility. Andrologia 2012;44 Suppl 1:560-4. [PMID: 21943018 DOI: 10.1111/j.1439-0272.2011.01227.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
63 Knappskog S, Lønning PE. MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk. Oncotarget 2011;2:251-8. [PMID: 21436469 DOI: 10.18632/oncotarget.243] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
64 Suo C, Xu H, Khor CC, Ong RT, Sim X, Chen J, Tay WT, Sim KS, Zeng YX, Zhang X, Liu J, Tai ES, Wong TY, Chia KS, Teo YY. Natural positive selection and north-south genetic diversity in East Asia. Eur J Hum Genet 2012;20:102-10. [PMID: 21792231 DOI: 10.1038/ejhg.2011.139] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
65 Sümbül AT, Akkız H, Bayram S, Bekar A, Akgöllü E, Sandıkçı M. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. Mol Biol Rep. 2012;39:1639-1647. [PMID: 21607615 DOI: 10.1007/s11033-011-0903-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
66 Khan MM, Rydén AM, Chowdhury MS, Hasan MA, Kazi JU. Maximum likelihood analysis of mammalian p53 indicates the presence of positively selected sites and higher tumorigenic mutations in purifying sites. Gene 2011;483:29-35. [PMID: 21640173 DOI: 10.1016/j.gene.2011.05.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
67 Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IM, Kurman RJ. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol 2011;24:1248-53. [DOI: 10.1038/modpathol.2011.85] [Cited by in Crossref: 277] [Cited by in F6Publishing: 289] [Article Influence: 25.2] [Reference Citation Analysis]
68 Hancock AM, Witonsky DB, Alkorta-Aranburu G, Beall CM, Gebremedhin A, Sukernik R, Utermann G, Pritchard JK, Coop G, Di Rienzo A. Adaptations to climate-mediated selective pressures in humans. PLoS Genet 2011;7:e1001375. [PMID: 21533023 DOI: 10.1371/journal.pgen.1001375] [Cited by in Crossref: 198] [Cited by in F6Publishing: 160] [Article Influence: 18.0] [Reference Citation Analysis]
69 Ito A, Morita A, Ohya S, Yamamoto S, Enomoto A, Ikekita M. Cycloheximide suppresses radiation-induced apoptosis in MOLT-4 cells with Arg72 variant of p53 through translational inhibition of p53 accumulation. J Radiat Res 2011;52:342-50. [PMID: 21467739 DOI: 10.1269/jrr.10151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
70 Ihsan R, Devi TR, Yadav DS, Mishra AK, Sharma J, Zomawia E, Verma Y, Phukan R, Mahanta J, Kataki AC, Kapur S, Saxena S. Investigation on the Role of p53 Codon 72 Polymorphism and Interactions with Tobacco, Betel Quid, and Alcohol in Susceptibility to Cancers in a High-Risk Population from North East India. DNA and Cell Biology 2011;30:163-71. [DOI: 10.1089/dna.2010.1119] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
71 Sucheston L, Witonsky DB, Hastings D, Yildiz O, Clark VJ, Di Rienzo A, Onel K. Natural selection and functional genetic variation in the p53 pathway. Hum Mol Genet 2011;20:1502-8. [PMID: 21266458 DOI: 10.1093/hmg/ddr028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
72 Frank AK, Leu JI, Zhou Y, Devarajan K, Nedelko T, Klein-Szanto A, Hollstein M, Murphy ME. The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammation. Mol Cell Biol 2011;31:1201-13. [PMID: 21245379 DOI: 10.1128/MCB.01136-10] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
73 Phang BH, Chua HW, Li H, Linn YC, Sabapathy K. Characterization of novel and uncharacterized p53 SNPs in the Chinese population--intron 2 SNP co-segregates with the common codon 72 polymorphism. PLoS One 2011;6:e15320. [PMID: 21249215 DOI: 10.1371/journal.pone.0015320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
74 Caamaño J, Saavedra N, Jaramillo PC, Lanas C, Lanas F, Salazar LA. <i>TP53</i> Codon 72 Polymorphism Is Associated with Coronary Artery Disease in Chilean Subjects. Med Princ Pract 2011;20:171-6. [DOI: 10.1159/000321206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
75 Kourosh AS, Harrington CR, Adinoff B. Tanning as a behavioral addiction. Am J Drug Alcohol Abuse 2010;36:284-90. [PMID: 20545604 DOI: 10.3109/00952990.2010.491883] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
76 Francisco G, Menezes PR, Eluf-Neto J, Chammas R. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer. 2011;129:920-930. [PMID: 20886596 DOI: 10.1002/ijc.25710] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
77 Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, Wani S, Siddiqi M. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genetics and Cytogenetics 2010;203:263-8. [DOI: 10.1016/j.cancergencyto.2010.08.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
78 Ricks-Santi L, Mason T, Apprey V, Ahaghotu C, McLauchlin A, Josey D, Bonney G, Dunston GM. p53 Pro72Arg polymorphism and prostate cancer in men of African descent. Prostate 2010;70:1739-45. [PMID: 20593380 DOI: 10.1002/pros.21209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
79 Yang M, Zhang L, Bi N, Ji W, Tan W, Zhao L, Yu D, Wu C, Wang L, Lin D. Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2011;79:1402-7. [PMID: 20729006 DOI: 10.1016/j.ijrobp.2009.12.042] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
80 Coop G, Witonsky D, Di Rienzo A, Pritchard JK. Using environmental correlations to identify loci underlying local adaptation. Genetics 2010;185:1411-23. [PMID: 20516501 DOI: 10.1534/genetics.110.114819] [Cited by in Crossref: 495] [Cited by in F6Publishing: 398] [Article Influence: 41.3] [Reference Citation Analysis]
81 Ferreira da Silva I, Koifman RJ, Quinto Santos Souza C, Ferreira de Almeida Neto O, Koifman S. TP53 Genetic Polymorphisms and Environmental Risk Factors Associated with Cervical Carcinogenesis in A Cohort of Brazilian Women with Cervical Lesions. Journal of Toxicology and Environmental Health, Part A 2010;73:888-900. [DOI: 10.1080/15287391003744823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
82 Alawadi S, Ghabreau L, Alsaleh M, Abdulaziz Z, Rafeek M, Akil N, Alkhalaf M. P53 gene polymorphisms and breast cancer risk in Arab women. Med Oncol 2011;28:709-15. [DOI: 10.1007/s12032-010-9505-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
83 Saini R, Tang TH, Zain RB, Cheong SC, Musa KI, Saini D, Ismail AR, Abraham MT, Mustafa WM, Santhanam J. Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia. J Cancer Res Clin Oncol 2011;137:311-20. [PMID: 20419384 DOI: 10.1007/s00432-010-0886-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
84 Henríquez-Hernández LA, Pérez LF, Hernández AG, de León AC, Díaz-Chico B, Rosales AM. TYMS, MTHFR, p53 and MDR1 gene polymorphisms in breast cancer patients treated with adjuvant therapy. Cancer Epidemiol 2010;34:490-3. [PMID: 20371218 DOI: 10.1016/j.canep.2010.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
85 Jiang P, Liu J, Zeng X, Li W, Tang J. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women. Cancer Genetics and Cytogenetics 2010;197:174-8. [DOI: 10.1016/j.cancergencyto.2009.11.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
86 Jeong BS, Hu W, Belyi V, Rabadan R, Levine AJ. Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis. FASEB J. 2010;24:1347-1353. [PMID: 20019240 DOI: 10.1096/fj.09-146001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
87 Miller AJ, Tsao H. New insights into pigmentary pathways and skin cancer. Br J Dermatol 2010;162:22-8. [PMID: 19863502 DOI: 10.1111/j.1365-2133.2009.09565.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
88 Novembre J, Di Rienzo A. Spatial patterns of variation due to natural selection in humans. Nat Rev Genet 2009;10:745-55. [PMID: 19823195 DOI: 10.1038/nrg2632] [Cited by in Crossref: 145] [Cited by in F6Publishing: 128] [Article Influence: 11.2] [Reference Citation Analysis]
89 Contu SS, Agnes G, Damin AP, Contu PC, Rosito MA, Alexandre CO, Damin DC. Lack of correlation between p53 codon 72 polymorphism and anal cancer risk. World J Gastroenterol 2009; 15(36): 4566-4570 [PMID: 19777616 DOI: 10.3748/wjg.15.4566] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
90 Sobti RC, Kaur P, Kaur S, Janmeja AK, Jindal SK, Kishan J, Raimondi S. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. DNA Cell Biol 2009;28:443-9. [PMID: 19558213 DOI: 10.1089/dna.2008.0797] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
91 Scacchi R, Gambina G, Moretto G, Corbo RM. Association study between P53 and P73 gene polymorphisms and the sporadic late-onset form of Alzheimer's disease. J Neural Transm (Vienna) 2009;116:1179-84. [PMID: 19657586 DOI: 10.1007/s00702-009-0276-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
92 Hrstka R, Coates PJ, Vojtesek B. Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment. J Cell Mol Med. 2009;13:440-453. [PMID: 19379143 DOI: 10.1111/j.1582-4934.2008.00634.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
93 Koshiol J, Hildesheim A, Gonzalez P, Bratti MC, Porras C, Schiffman M, Herrero R, Rodriguez AC, Wacholder S, Yeager M, Chanock SJ, Burk RD, Wang SS. Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited. Cancer Epidemiol Biomarkers Prev 2009;18:1631-7. [PMID: 19423538 DOI: 10.1158/1055-9965.EPI-08-0830] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
94 Hancox RJ, Poulton R, Welch D, Olova N, McLachlan CR, Greene JM, Sears MR, Caspi A, Moffitt TE, Robertson SP, Braithwaite AW. Accelerated decline in lung function in cigarette smokers is associated with TP53/MDM2 polymorphisms. Hum Genet 2009;126:559-65. [PMID: 19521721 DOI: 10.1007/s00439-009-0704-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
95 Shi H, Tan SJ, Zhong H, Hu W, Levine A, Xiao CJ, Peng Y, Qi XB, Shou WH, Ma RL, Li Y, Su B, Lu X. Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am J Hum Genet 2009;84:534-41. [PMID: 19344876 DOI: 10.1016/j.ajhg.2009.03.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
96 Szoke D, Molnár B, Solymosi N, Sipos F, Galamb O, Gyorffy A, Tulassay Z. The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia. Dig Liver Dis 2009;41:179-84. [PMID: 18567547 DOI: 10.1016/j.dld.2008.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
97 Imyanitov EN. Gene polymorphisms, apoptotic capacity and cancer risk. Hum Genet 2009;125:239-46. [DOI: 10.1007/s00439-009-0636-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
98 Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009;9:95-107. [PMID: 19165225 DOI: 10.1038/nrc2584] [Cited by in Crossref: 427] [Cited by in F6Publishing: 412] [Article Influence: 32.8] [Reference Citation Analysis]
99 Vazquez A, Bond EE, Levine AJ, Bond GL. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 2008;7:979-87. [PMID: 19043449 DOI: 10.1038/nrd2656] [Cited by in Crossref: 438] [Cited by in F6Publishing: 433] [Article Influence: 31.3] [Reference Citation Analysis]
100 Khan SA, Idrees K, Forslund A, Zeng Z, Rosenberg S, Pincas H, Barany F, Offit K, Laquaglia MP, Paty PB. Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer. J Surg Oncol 2008;97:621-5. [PMID: 18381604 DOI: 10.1002/jso.20996] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
101 McGowan KA, Li JZ, Park CY, Beaudry V, Tabor HK, Sabnis AJ, Zhang W, Fuchs H, de Angelis MH, Myers RM, Attardi LD, Barsh GS. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 2008;40:963-70. [PMID: 18641651 DOI: 10.1038/ng.188] [Cited by in Crossref: 259] [Cited by in F6Publishing: 258] [Article Influence: 18.5] [Reference Citation Analysis]
102 Zhu ZZ, Wang AZ, Jia HR, Jin XX, He XL, Hou LF, Zhu G. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol. 2007;37:385-390. [PMID: 17599946 DOI: 10.1093/jjco/hym034] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
103 Hancock AM, Witonsky DB, Gordon AS, Eshel G, Pritchard JK, Coop G, Di Rienzo A. Adaptations to climate in candidate genes for common metabolic disorders. PLoS Genet 2008;4:e32. [PMID: 18282109 DOI: 10.1371/journal.pgen.0040032] [Cited by in Crossref: 198] [Cited by in F6Publishing: 180] [Article Influence: 14.1] [Reference Citation Analysis]
104 Nan H, Qureshi AA, Hunter DJ, Han J. Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk. Br J Dermatol 2008;159:314-21. [PMID: 18510673 DOI: 10.1111/j.1365-2133.2008.08624.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
105 Shao Y, Tan W, Zhang S. P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population. Dis Esophagus 2008;21:139-43. [PMID: 18269649 DOI: 10.1111/j.1442-2050.2007.00746.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
106 Phang BH, Linn YC, Li H, Sabapathy K. MDM2 SNP309 G allele decreases risk but does not affect onset age or survival of Chinese leukaemia patients. European Journal of Cancer 2008;44:760-6. [DOI: 10.1016/j.ejca.2008.02.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
107 Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A, Amorim J, Lopes JM, Reis RM. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer Genet Cytogenet 2008;180:14-9. [PMID: 18068527 DOI: 10.1016/j.cancergencyto.2007.08.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
108 Lum SS, Chua HW, Li H, Li WF, Rao N, Wei J, Shao Z, Sabapathy K. MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population. Carcinogenesis. 2008;29:754-761. [PMID: 18281248 DOI: 10.1093/carcin/bgn024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
109 Palmero EI, Schüler-Faccini L, Caleffi M, Achatz MI, Olivier M, Martel-Planche G, Marcel V, Aguiar E, Giacomazzi J, Ewald IP, Giugliani R, Hainaut P, Ashton-Prolla P. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Cancer Lett 2008;261:21-5. [PMID: 18248785 DOI: 10.1016/j.canlet.2007.10.044] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 5.0] [Reference Citation Analysis]
110 Oliveira S, Sousa H, Santos A, Pinto D, Pinto-correia A, Fontoura D, Moutinho J, Medeiros R. The p53 R72P polymorphism does not influence cervical cancer development in a portuguese population: A study in exfoliated cervical cells. J Med Virol 2008;80:424-9. [DOI: 10.1002/jmv.21103] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
111 Spitsina EV, Yakunina NY, Chudakova DA, Nikitin AG, Svetlova GN, Soluyanova TN, Strokov IA, Nosikov VV. The association of the TP53 polymorphisms Pro72Arg and C(−594)CC with diabetic polyneuropathy in Russian Muscovites with type 1 diabetes mellitus. Mol Biol 2007;41:901-5. [DOI: 10.1134/s0026893307060052] [Cited by in Crossref: 9] [Article Influence: 0.6] [Reference Citation Analysis]
112 Soussi T, Wiman KG. Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 2007;12:303-12. [PMID: 17936556 DOI: 10.1016/j.ccr.2007.10.001] [Cited by in Crossref: 240] [Cited by in F6Publishing: 220] [Article Influence: 16.0] [Reference Citation Analysis]
113 Kashkin KN, Khlgatian SV, Gurova OV, Kuprash DV, Nedospasov SA. New mutations in the human p53 gene--a regulator of the cell cycle and carcinogenesis. Biochemistry (Mosc) 2007;72:282-92. [PMID: 17447881 DOI: 10.1134/s0006297907030054] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
114 Govan VA, Loubser S, Saleh D, Hoffman M, Williamson AL. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency. Int J Immunogenet 2007;34:213-7. [PMID: 17504512 DOI: 10.1111/j.1744-313X.2007.00678.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
115 Perrone F, Mariani L, Pastore E, Orsenigo M, Suardi S, Marcomini B, DaRiva L, Licitra L, Carbone A, Pierotti MA, Pilotti S. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx. Cancer 2007;109:2461-5. [PMID: 17492690 DOI: 10.1002/cncr.22702] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
116 Kashima T, Makino K, Soemantri A, Ishida T. TP53 codon 72 polymorphism in 12 populations of insular Southeast Asia and Oceania. J Hum Genet 2007;52:694-7. [DOI: 10.1007/s10038-007-0168-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
117 Ezzikouri S, El Feydi AE, Chafik A, Benazzouz M, El Kihal L, Afifi R, Hassar M, Pineau P, Benjelloun S. The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population. Hepatol Res 2007;37:748-54. [PMID: 17573955 DOI: 10.1111/j.1872-034X.2007.00126.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
118 Bellei B, Cota C, Amantea A, Muscardin L, Picardo M. Association of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides. Br J Dermatol 2006;155:1223-9. [PMID: 17107393 DOI: 10.1111/j.1365-2133.2006.07527.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
119 Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007;26:2157-65. [PMID: 17401424 DOI: 10.1038/sj.onc.1210302] [Cited by in Crossref: 563] [Cited by in F6Publishing: 565] [Article Influence: 37.5] [Reference Citation Analysis]
120 Perfumo C, Bonelli L, Menichini P, Inga A, Gismondi V, Ciferri E, Percivale P, Bianchi Scarrà G, Nasti S, Fronza G, Varesco L. Increased Risk of Colorectal Adenomas in Italian Subjects Carrying the <i>p53</i> PIN3 A2-Pro72 Haplotype. Digestion 2007;74:228-35. [DOI: 10.1159/000100966] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
121 Atwal GS, Bond GL, Metsuyanim S, Papa M, Friedman E, Distelman-Menachem T, Ben Asher E, Lancet D, Ross DA, Sninsky J, White TJ, Levine AJ, Yarden R. Haplotype structure and selection of the MDM2 oncogene in humans. Proc Natl Acad Sci U S A 2007;104:4524-9. [PMID: 17360557 DOI: 10.1073/pnas.0610998104] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
122 Oren M, Bartek J. The Sunny Side of p53. Cell 2007;128:826-8. [DOI: 10.1016/j.cell.2007.02.027] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
123 Stefanaki I, Stratigos A, Dimisianos G, Nikolaou V, Papadopoulos O, Polydorou D, Gogas H, Tsoutsos D, Panagiotou P, Kanavakis E, Antoniou C, Katsambas A. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants. Br J Dermatol 2007;156:357-62. [DOI: 10.1111/j.1365-2133.2006.07645.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 266] [Article Influence: 1.7] [Reference Citation Analysis]
124 Nadji SA, Mahmoodi M, Ziaee AA, Naghshvar F, Torabizadeh J, Yahyapour Y, Nategh R, Mokhtari-Azad T. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran. Lung Cancer 2007;56:145-51. [PMID: 17208332 DOI: 10.1016/j.lungcan.2006.12.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
125 Phang BH, Sabapathy K. The codon 72 polymorphism-specific effects of human p53 are absent in mouse cells: implications on generation of mouse models. Oncogene 2007;26:2964-74. [DOI: 10.1038/sj.onc.1210112] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
126 Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, Giovannucci EL, Hunter DJ. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer. 2006;119:1863-1868. [PMID: 16721787 DOI: 10.1002/ijc.22057] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
127 Crespi BJ, Summers K. Positive selection in the evolution of cancer. Biol Rev Camb Philos Soc 2006;81:407-24. [PMID: 16762098 DOI: 10.1017/S1464793106007056] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
128 Han J, Cox DG, Colditz GA, Hunter DJ. The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US caucasian women: p53 CODON 72 POLYMORPHISM AND SKIN CANCER. Mol Carcinog 2006;45:694-700. [DOI: 10.1002/mc.20190] [Cited by in Crossref: 36] [Cited by in F6Publishing: 277] [Article Influence: 2.3] [Reference Citation Analysis]
129 Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53. Int J Cancer 2006;118:2479-84. [PMID: 16353134 DOI: 10.1002/ijc.21661] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
130 Morari EC, Lima AB, Bufalo NE, Leite JL, Granja F, Ward LS. Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. J Cancer Res Clin Oncol 2006;132:521-8. [PMID: 16788846 DOI: 10.1007/s00432-006-0099-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
131 Wegman P, Stal O, Stenmark Askmalm M, Nordenskjöld B, Rutqvist L, Wingren S. p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients. Pharmacogenetics and Genomics 2006;16:347-51. [DOI: 10.1097/01.fpc.0000204997.84182.69] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
132 Murphy ME. Polymorphic variants in the p53 pathway. Cell Death Differ 2006;13:916-20. [DOI: 10.1038/sj.cdd.4401907] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 3.9] [Reference Citation Analysis]
133 Wasielewski M, Elstrodt F, Klijn JG, Berns EM, Schutte M. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. Breast Cancer Res Treat 2006;99:97-101. [DOI: 10.1007/s10549-006-9186-z] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
134 Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene 2006;25:1602-11. [DOI: 10.1038/sj.onc.1209367] [Cited by in Crossref: 151] [Cited by in F6Publishing: 141] [Article Influence: 9.4] [Reference Citation Analysis]
135 Pérez LO, Abba MC, Dulout FN, Golijow CD. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol 2006; 12(9): 1426-1429 [PMID: 16552814 DOI: 10.3748/wjg.v12.i9.1426] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
136 Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer 2006;52:9-14. [PMID: 16499995 DOI: 10.1016/j.lungcan.2005.12.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
137 Puente XS, Velasco G, Gutiérrez-Fernández A, Bertranpetit J, King MC, López-Otín C. Comparative analysis of cancer genes in the human and chimpanzee genomes. BMC Genomics. 2006;7:15. [PMID: 16438707 DOI: 10.1186/1471-2164-7-15] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
138 Jain N, Singh V, Hedau S, Kumar S, Daga MK, Dewan R, Murthy NS, Husain SA, Das BC. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 2005;128:3999-4007. [PMID: 16354872 DOI: 10.1378/chest.128.6.3999] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
139 Twu C, Jiang R, Shu C, Lin J. Association of p53 Codon 72 Polymorphism with Risk of Hypopharyngeal Squamous Cell Carcinoma in Taiwan. Journal of the Formosan Medical Association 2006;105:99-104. [DOI: 10.1016/s0929-6646(09)60330-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
140 Damin AP, Frazzon AP, Damin DC, Roehe A, Hermes V, Zettler C, Alexandre CO. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Cancer Detection and Prevention 2006;30:523-9. [DOI: 10.1016/j.cdp.2006.09.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
141 Bhattacharya P, Sengupta S. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women. Gynecol Oncol 2005;99:176-82. [PMID: 16054204 DOI: 10.1016/j.ygyno.2005.06.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
142 Gwosdz C, Scheckenbach K, Lieven O, Reifenberger J, Knopf A, Bier H, Balz V. Comprehensive analysis of the p53 status in mucosal and cutaneous melanomas. Int J Cancer 2006;118:577-82. [DOI: 10.1002/ijc.21366] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
143 Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 2005;79:7014-23. [PMID: 15890941 DOI: 10.1128/JVI.79.11.7014-7023.2005] [Cited by in Crossref: 119] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
144 Le Roux E, Gormally E, Hainaut P. Somatic mutations in human cancer: applications in molecular epidemiology. Revue d'Épidémiologie et de Santé Publique 2005;53:257-66. [DOI: 10.1016/s0398-7620(05)84603-6] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
145 Pérez-Pérez GI, Bosques-Padilla FJ, Crosatti ML, Tijerina-Menchaca R, Garza-González E. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol 2005;40:56-60. [PMID: 15841715 DOI: 10.1080/00365520410009456] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
146 de Moura Gallo CV, Azevedo E Silva Mendonça G, de Moraes E, Olivier M, Hainaut P. TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives. Mutat Res 2005;589:192-207. [PMID: 15878142 DOI: 10.1016/j.mrrev.2005.01.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
147 Zhu ZZ, Cong WM, Liu SF, Dong H, Zhu GS, Wu MC. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population. World J Gastroenterol 2005; 11(2): 289-292 [PMID: 15633234 DOI: 10.3748/wjg.v11.i2.289] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
148 Harris S, Gil G, Hu W, Robins H, Bond E, Hirshfield K, Feng Z, Yu X, Teresky A, Bond G, Levine A. Single-Nucleotide Polymorphisms in the p53 Pathway. Cold Spring Harbor Symposia on Quantitative Biology 2005;70:111-9. [DOI: 10.1101/sqb.2005.70.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
149 Tornesello ML, Waddell KM, Duraturo ML, Biryahwaho B, Downing R, Lucas SB, Giani U, Buonaguro L, Buonaguro FM. TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda. Cancer Detection and Prevention 2005;29:501-8. [DOI: 10.1016/j.cdp.2005.08.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
150 Settheetham-ishida W, Singto Y, Yuenyao P, Tassaneeyakul W, Kanjanavirojkul N, Ishida T. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand. Cancer Letters 2004;210:205-11. [DOI: 10.1016/j.canlet.2004.03.039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
151 de Oliveira WRP, Rady PL, Grady J, Hughes TK, Neto CF, Rivitti EA, Tyring SK. Association of p53 arginine polymorphism with skin cancer. Int J Dermatol 2004;43:489-93. [DOI: 10.1111/j.1365-4632.2004.02289.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
152 Favis R, Huang J, Gerry NP, Culliford A, Paty P, Soussi T, Barany F. Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors. Hum Mutat 2004;24:63-75. [DOI: 10.1002/humu.20069] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
153 Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, Husain SA, Das BC. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem 2003;252:117-24. [PMID: 14577584 DOI: 10.1023/a:1025546610920] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]
154 Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-dale A, Helland Å. Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma: TP53 VARIATION AND ADVANCED OVARIAN CANCER. Hum Mutat 2004;24:21-34. [DOI: 10.1002/humu.20055] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
155 Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004;6:443-50. [PMID: 15077116 DOI: 10.1038/ncb1123] [Cited by in Crossref: 538] [Cited by in F6Publishing: 499] [Article Influence: 29.9] [Reference Citation Analysis]
156 Porrello A, Soddu S, Zbilut JP, Crescenzi M, Giuliani A. Discrimination of single amino acid mutations of the p53 protein by means of deterministic singularities of recurrence quantification analysis. Proteins 2004;55:743-55. [DOI: 10.1002/prot.20075] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
157 Hu N, Li WJ, Su H, Wang C, Goldstein AM, Albert PS, Emmert-Buck MR, Kong LH, Roth MJ, Dawsey SM, He LJ, Cao SF, Ding T, Giffen C, Taylor PR. Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China. Cancer Detect Prev 2003;27:132-8. [PMID: 12670525 DOI: 10.1016/s0361-090x(03)00031-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
158 Brenna SMF, Silva IDCGD, Zeferino LC, Pereira J, Martinez EZ, Syrjänen KJ. Prevalence of codon 72 P53 polymorphism in Brazilian women with cervix cancer. Genet Mol Biol 2004;27:496-9. [DOI: 10.1590/s1415-47572004000400005] [Cited by in Crossref: 10] [Article Influence: 0.6] [Reference Citation Analysis]
159 Liu S, Bishop WR, Dasmahapatra B, Wang Y. Pharmacogenomics of the p53 tumor suppressor and its role in cancer chemoresistance. Drug Dev Res 2004;62:254-72. [DOI: 10.1002/ddr.10362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
160 . P53 codon 72 polymorphism and BRCA 1 and 2 mutations in ovarian epithelial malignancies in black South Africans. Int J Gynecol Cancer 2003;13:444-9. [DOI: 10.1046/j.1525-1438.2003.13333.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
161 Tiwawech D, Srivatanakul P, Karaluk A, Ishida T. The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Letters 2003;198:69-75. [DOI: 10.1016/s0304-3835(03)00283-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
162 Humbey O, Cairey-Remonnay S, Guérrini JS, Algros MP, Mougin C, Bittard H, Aubin F. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. Eur J Cancer. 2003;39:684-690. [PMID: 12628849 DOI: 10.1016/s0959-8049(02)00835-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
163 Govan VA, Carrara HR, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog. 2003;2:3. [PMID: 12809559 DOI: 10.1186/1477-3163-2-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
164 Arbel-Alon S, Menczer J, Feldman N, Glezerman M, Yeremin L, Friedman E. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women. Int J Gynecol Cancer 2002;12:741-4. [PMID: 12445252 DOI: 10.1046/j.1525-1438.2002.01124.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
165 Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357-365. [PMID: 12567188 DOI: 10.1038/ng1093] [Cited by in Crossref: 864] [Cited by in F6Publishing: 850] [Article Influence: 45.5] [Reference Citation Analysis]
166 Kuroda Y, Tsukino H, Nakao H, Imai H, Katoh T. p53 Codon 72 polymorphism and urothelial cancer risk. Cancer Lett. 2003;189:77-83. [PMID: 12445680 DOI: 10.1016/s0304-3835(02)00518-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
167 Bhattacharya P, Duttagupta C, Sengupta S. Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women. Cancer Lett 2002;188:207-11. [PMID: 12406566 DOI: 10.1016/s0304-3835(02)00430-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
168 Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, Mei Q, Ke Y. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer. 2002;95:2571-2576. [PMID: 12467072 DOI: 10.1002/cncr.11008] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 3.0] [Reference Citation Analysis]
169 Papadakis ED, Soulitzis N, Spandidos DA. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer. 2002;87:1013-1018. [PMID: 12434294 DOI: 10.1038/sj.bjc.6600595] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 3.2] [Reference Citation Analysis]
170 Suspitsin EN, Buslov KG, Grigoriev MY, Ishutkina JG, Ulibina JM, Gorodinskaya VM, Pozharisski KM, Berstein LM, Hanson KP, Togo AV, Imyanitov EN. Evidence against involvement of p53 polymorphism in breast cancer predisposition. Int J Cancer 2003;103:431-3. [DOI: 10.1002/ijc.10834] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
171 Bonafè M, Salvioli S, Barbi C, Mishto M, Trapassi C, Gemelli C, Storci G, Olivieri F, Monti D, Franceschi C. p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes. Biochemical and Biophysical Research Communications 2002;299:539-41. [DOI: 10.1016/s0006-291x(02)02691-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
172 Sanclemente G, Gill DK. Human papillomavirus molecular biology and pathogenesis. J Eur Acad Dermatol Venereol. 2002;16:231-240. [PMID: 12195562 DOI: 10.1046/j.1473-2165.2002.00419.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
173 Gaspar PA, Hutz MH, Salzano FM, Hill K, Hurtado AM, Petzl-erler ML, Tsuneto LT, Weimer TA. Polymorphisms ofCYP1a1,CYP2e1,GSTM1,GSTT1, andTP53 genes in Amerindians. Am J Phys Anthropol 2002;119:249-56. [DOI: 10.1002/ajpa.10128] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
174 Pegoraro RJ, Rom L, Lanning PA, Moodley M, Naiker S, Moodley J. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women. Int J Gynecol Cancer 2002;12:383-8. [PMID: 12144687 DOI: 10.1046/j.1525-1438.2002.01109.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
175 Mcgregor JM, Harwood CA, Brooks L, Kelly DA, O’nions J, Young AR, Surentheran T, Breuer J, Millard TP, Lewis CM, Leigh IM, Storey A, Crook T, Fisher SA. Relationship Between p53 Codon 72 Polymorphism and Susceptibility to Sunburn and Skin Cancer. Journal of Investigative Dermatology 2002;119:84-90. [DOI: 10.1046/j.1523-1747.2002.01655.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 301] [Article Influence: 3.1] [Reference Citation Analysis]
176 Tan T, Chu G. p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol Cell Biol 2002;22:3247-54. [PMID: 11971958 DOI: 10.1128/MCB.22.10.3247-3254.2002] [Cited by in Crossref: 123] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
177 Cairey-remonnay S, Humbey O, Mougin C, Algros MP, Mauny F, Kanitakis J, Euvrard S, Laurent R, Aubin F. TP53 Polymorphism of Exon 4 at Codon 72 in Cutaneous Squamous Cell Carcinoma and Benign Epithelial Lesions of Renal Transplant Recipients and Immunocompetent Individuals: Lack of Correlation with Human Papillomavirus Status11This work was presented in part at the 19th International Papillomavirus Conference in Florianopolis, Brazil, September 1–7, 2001. Journal of Investigative Dermatology 2002;118:1026-31. [DOI: 10.1046/j.1523-1747.2002.01787.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
178 Humbey O, Aubin F, Cairey-remonnay S, Riethmuller D, Pretet JL, Fest T, Seilles E, Mougin C. TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions. European Journal of Obstetrics & Gynecology and Reproductive Biology 2002;103:60-4. [DOI: 10.1016/s0301-2115(02)00006-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
179 Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Letters 2002;179:175-83. [DOI: 10.1016/s0304-3835(01)00867-9] [Cited by in Crossref: 91] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
180 Soussi T, Béroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001;1:233-40. [PMID: 11902578 DOI: 10.1038/35106009] [Cited by in Crossref: 444] [Cited by in F6Publishing: 405] [Article Influence: 22.2] [Reference Citation Analysis]
181 Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC, Tsai CH. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope. 2002;112:116-119. [PMID: 11802048 DOI: 10.1097/00005537-200201000-00020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
182 Portwine C, Chilton-MacNeill S, Brown C, Sexsmith E, McLaughlin J, Malkin D. Absence of germline and somatic p53 alterations in children with sporadic brain tumors. J Neurooncol 2001;52:227-35. [PMID: 11519852 DOI: 10.1023/a:1010661831335] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
183 Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (oscc) patients of Eastern India. Int J Cancer 2002;97:649-53. [DOI: 10.1002/ijc.10112] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 3.9] [Reference Citation Analysis]
184 Sourvinos G, Rizos E, Spandidos D. p53 codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours. Oral Oncology 2001;37:572-8. [DOI: 10.1016/s1368-8375(00)00139-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
185 O'Connor DP, Kay EW, Leader M, Atkins GJ, Murphy GM, Mabruk MJ. p53 codon 72 polymorphism and human papillomavirus associated skin cancer. J Clin Pathol 2001;54:539-42. [PMID: 11429426 DOI: 10.1136/jcp.54.7.539] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
186 Biroš E, Kalina I, Kohút A, Štubňa J, Šalagovič J. Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer 2001;31:157-62. [DOI: 10.1016/s0169-5002(00)00188-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
187 Duzhak T, Mitrofanov D, Ostashevskii V, Gutkina N, Chasovnikova O, Posukh O, Osipova L, Lyakhovich VV. Genetic polymorphisms of CYP2D6, CYP1A1, GSTM1 and p53 genes in a unique Siberian population of Tundra Nentsi. Pharmacogenetics 2000;10:531-7. [PMID: 10975607 DOI: 10.1097/00008571-200008000-00006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
188 Bastiaens MT, Struyk L, Tjong-a-hung SP, Gruis N, ter Huurne J, Westendorp RGJ, Vermeer BJ, Bavinck JNB, ter Schegget J. Cutaneous squamous cell carcinoma andp53 codon 72 polymorphism: A need for screening? Mol Carcinog 2001;30:56-61. [DOI: 10.1002/1098-2744(200101)30:1<56::aid-mc1013>3.0.co;2-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
189 Kim JW, Roh JW, Park NH, Song YS, Kang SB, Lee HP. Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women. Am J Obstet Gynecol 2001;184:55-8. [PMID: 11174479 DOI: 10.1067/mob.2001.108329] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
190 Pegoraro R, Moodley J, Naiker S, Lanning P, Rom L. The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer. BJOG 2000;107:1164-5. [PMID: 11002963 DOI: 10.1111/j.1471-0528.2000.tb11118.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
191 Agorastos T, Lambropoulos AF, Constantinidis TC, Kotsis A, Bontis JN. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev 2000;9:113-8. [PMID: 10830578 DOI: 10.1097/00008469-200004000-00007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
192 Nishikawa A, Fujimoto T, Akutagawa N, Iwasaki M, Takeuchi M, Fujinaga K, Kudo R. p53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer. Int J Gynecol Cancer 2000;10:402-7. [PMID: 11240705 DOI: 10.1046/j.1525-1438.2000.010005402.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
193 Khaliq S, Hameed A, Khaliq T, Ayub Q, Qamar R, Mohyuddin A, Mazhar K, Qasim-Mehdi S. P53 mutations, polymorphisms, and haplotypes in Pakistani ethnic groups and breast cancer patients. Genet Test 2000;4:23-9. [PMID: 10794357 DOI: 10.1089/109065700316435] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
194 Malcolm EK, Baber GB, Boyd JC, Stoler MH. Polymorphism at codon 72 of p53 is not associated with cervical cancer risk. Mod Pathol 2000;13:373-8. [PMID: 10786802 DOI: 10.1038/modpathol.3880061] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
195 Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, DeVoe G, Miller MA, Wang J, Noffsinger A. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology. 2000;118:1039-1044. [PMID: 10833478 DOI: 10.1016/s0016-5085(00)70356-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
196 Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47-54. [PMID: 10802655 DOI: 10.1038/75586] [Cited by in Crossref: 326] [Cited by in F6Publishing: 334] [Article Influence: 14.8] [Reference Citation Analysis]
197 Shih CM, Lin PT, Wang HC, Huang WC, Wang YC. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan. Jpn J Cancer Res 2000;91:9-15. [PMID: 10744039 DOI: 10.1111/j.1349-7006.2000.tb00854.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
198 Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol 2000;114:444-55. [PMID: 10692102 DOI: 10.1046/j.1523-1747.2000.00869.x] [Cited by in Crossref: 168] [Cited by in F6Publishing: 155] [Article Influence: 7.6] [Reference Citation Analysis]
199 van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ, Walboomers JM. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 2000;81:317-25. [PMID: 10644829 DOI: 10.1099/0022-1317-81-2-317] [Cited by in Crossref: 55] [Cited by in F6Publishing: 64] [Article Influence: 2.5] [Reference Citation Analysis]
200 Tong D, Kucera E, Stimpfl M, Kölbl H, Leodolter S, Zeillinger R. Detection of p53 Polymorphism at Codon 72 by PCR and Allele-specific Oligonucleotide Hybridization on Microtiter Plates. Clinical Chemistry 2000;46:124-6. [DOI: 10.1093/clinchem/46.1.124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
201 Makni H, Franco EL, Kaiano J, Villa LL, Labrecque S, Dudley R, Storey A, Matlashewski G. p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 2000;87:528-33. [DOI: 10.1002/1097-0215(20000815)87:4<528::aid-ijc11>3.0.co;2-o] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
202 Sun Y, Keshava C, Sharp DS, Weston A, McCanlies EC. DNA sequence variants of p53: cancer and aging. Am J Hum Genet 1999;65:1779-82. [PMID: 10577934 DOI: 10.1086/302650] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
203 Ngan HY, Liu VW, Liu SS. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer 1999;80:1828-9. [PMID: 10468305 DOI: 10.1038/sj.bjc.6690606] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
204 Bertorelle R, Chieco-bianchi L, Del Mistro A. Papillomavirus andp53 codon 72 polymorphism. Int J Cancer 1999;82:616-7. [DOI: 10.1002/(sici)1097-0215(19990812)82:4<616::aid-ijc24>3.0.co;2-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
205 Maciag P, Villa L. Genetic susceptibility to HPV infection and cervical cancer. Braz J Med Biol Res 1999;32:915-22. [DOI: 10.1590/s0100-879x1999000700017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
206 Auer H, Warncke K, Nowak D, Koops F, Jaeger U, Kurzbauer R, Ruediger HW. Variations of p53 in Cultured Fibroblasts of Patients With Lung Cancer Who Have a Presumed Genetic Predisposition: . American Journal of Clinical Oncology 1999;22:278-82. [DOI: 10.1097/00000421-199906000-00013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
207 Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092-100. [PMID: 9891044 DOI: 10.1128/MCB.19.2.1092] [Cited by in Crossref: 460] [Cited by in F6Publishing: 178] [Article Influence: 20.0] [Reference Citation Analysis]
208 van der Zee AG, Hayes VM, Hofstra RM, Buys CH, Hollema H. Homozygous arginine-72 in wild type p53 and risk of cervical cancer. The Lancet 1998;352:1756. [DOI: 10.1016/s0140-6736(05)79829-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
209 . p53 polymorphisms at position 72 and development of cervical cancer. Int J Gynecol Cancer 1998;8:439-439. [DOI: 10.1046/j.1525-1438.1998.0le05.x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
210 Rosenthal AN, Ryan A, Al-jehani RM, Storey A, Harwood CA, Jacobs IJ. p53 codon 72 polymorphism and risk of cervical cancer in UK. The Lancet 1998;352:871-2. [DOI: 10.1016/s0140-6736(98)07357-7] [Cited by in Crossref: 108] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
211 Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998;393:229-234. [PMID: 9607760 DOI: 10.1038/30400] [Cited by in Crossref: 615] [Cited by in F6Publishing: 594] [Article Influence: 25.6] [Reference Citation Analysis]
212 Yung W, Ng M, Sham J, Choy D. p53 codon 72 polymorphism in nasopharyngeal carcinoma. Cancer Genetics and Cytogenetics 1997;93:181-2. [DOI: 10.1016/s0165-4608(96)00219-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]